Microneedle-array patch system applications in diabetes
DOI:
https://doi.org/10.54097/34w3ea84Keywords:
microneedle patch, responsive, insulin.Abstract
Diabetes is turning into a chronicle disease with further improved drugs and more facilitated delivery systems coming out. An essential part of the drugs is insulin and its analogs that patients with diabetes use to control their blood glucose levels. The conventional treatments, like injection and open-loop (release are not responsive) transdermal delivery, are short of maintaining glucose levels in the expected range incurring risks of hypoglycemia. Nevertheless, closed-loop drug delivery shows high potential as its release response to glucose levels dynamically. In the transdermal delivery field, microneedle (MN)-array patch systems presented great capability in transdermal delivery and manipulation. So, the glucose-responsive MN-array patches that make progress in safety and convenience were drawing worldwide focus. This review provides an overview of the topic and presents some advanced outcomes.
Downloads
References
Y. Ye et al., “Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery,” Advanced Materials, vol. 28, no. 16, pp. 3115 – 3121, 2016, doi: 10.1002/adma. 201506025.
J. Wang et al., “Core–Shell Microneedle Gel for Self-Regulated Insulin Delivery,” ACS Nano, vol. 12, no. 3, pp. 2466 – 2473, Mar. 2018, doi: 10.1021/acsnano.7b08152.
K. Ishihara, M. Kobayashi, N. Ishimaru, and I. Shinohara, “Glucose Induced Permeation Control of Insulin through a Complex Membrane Consisting of Immobilized Glucose Oxidase and a Poly (amine),” Polym J, vol. 16, no. 8, pp. 625–631, Aug. 1984, doi: 10.1295/polymj.16.625.
G. W. Albin, T. A. Horbett, S. R. Miller, and N. L. Ricker, “Theoretical and experimental studies of glucose sensitive membranes,” Journal of Controlled Release, vol. 6, no. 1, pp. 267 – 291, Dec. 1987, doi: 10.1016/0168 - 3659 (87) 90081 - 2.
J. Yu et al., “Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery,” Proc Natl Acad Sci U S A, vol. 112, no. 27, pp. 8260 – 8265, Jul. 2015, doi: 10.1073/pnas.1505405112.
X.-X. Yang, P. Feng, J. Cao, W. Liu, and Y. Tang, “Composition-Engineered Metal–Organic Framework-Based Microneedles for Glucose-Mediated Transdermal Insulin Delivery,” ACS Appl. Mater. Interfaces, vol. 12, no. 12, pp. 13613 – 13621, Mar. 2020, doi: 10.1021/acsami. 9b20774.
Y. Zhang et al., “Gold nanoclusters for controlled insulin release and glucose regulation in diabetes,” Nanoscale, vol. 11, no. 13, pp. 6471 – 6479, Mar. 2019, doi: 10.1039/C9NR00668K.
M. A. Rafiee et al., “Fracture and Fatigue in Graphene Nanocomposites,” Small, vol. 6, no. 2, pp. 179 – 183, 2010, doi: 10.1002/smll.200901480.
Z. Ye et al., “Polymeric Microneedle Arrays with Glucose-Sensing Dynamic-Covalent Bonding for Insulin Delivery,” Biomacromolecules, Sep. 2022, doi: 10.1021/acs.biomac. 2c00878.
R. Li et al., “3D-printed microneedle arrays for drug delivery,” Journal of Controlled Release, vol. 350, pp. 933 – 948, Oct. 2022, doi: 10.1016/j. jconrel. 2022. 08. 022.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
